No Data
Lifetech Sci (01302.HK): IBS absorbable drug-eluting coronary stent system announces the one-year follow-up results of Phase III clinical study.
Great Wall Power October 31st | Lifetech Sci (01302.HK) announced that the self-developed IBS absorbable drug-eluting coronary artery brackets system ("IBS coronary artery brackets") has successfully completed the Phase III clinical trial follow-up of one year, and on October 29, 2024, local time in the usa, Director Song Lei of the Fuwai Hospital of the Chinese Academy of Medical Sciences, on behalf of Academician Gao Runlin and all researchers, first presented the one-year major endpoint follow-up results of the Phase III clinical trial of IBS coronary artery brackets at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting to the global audience for the first time in 2024.
Hong Kong stock concept tracking | Medical devices trade-in program attracts institutional attention, clear trend of market recovery.
"Trade-in" is accelerating in the field of medical devices, and various provinces are intensively issuing "feasibility announcements", "project approval announcements" and "tender procurement notices", injecting a dose of "cardiotonic" into the market.
【Industry Trends】In 2024, on-site negotiations and bidding for medical insurance directory have begun; the cumulative number of licenses issued for domestic online games has exceeded one thousand.
In 2024, the on-site negotiation bidding for the medical insurance catalog will begin, and the results are scheduled to be announced at 8:30 a.m. on November 10 after starting officially in peking on October 27. According to the previously released information, from today (the 27th) to the 30th, a total of 162 pharmaceuticals will participate in the on-site negotiation and bidding. It is reported that this year, like before, there will be 25 negotiation experts from medical insurance departments selected from all over the country, divided into 5 groups, conducting negotiations on medical insurance payment prices, officially kicking off the medical insurance on-site negotiation and bidding. Source: CCTV news China's steel exports in the first three quarters of this year reached 8.
lifetech sci [01302] is now trading at 1.48 Hong Kong dollars, with a rise of 10.45%.
As of 13:11, lifetech sci [01302] reported HK$1.48, up HK$0.14 or 10.45% from the previous closing price of HK$1.34, with a turnover of 92.7037 million Hong Kong dollars. The highest price today was HK$1.48, and the lowest price was HK$1.35. Based on the previous closing price, the 10-day average price is HK$1.45, the 50-day average price is HK$1.49. The current pe ratio is 20.12 times, and the 14-day relative strength index is 24.73.
Strong performance of healthcare stocks, Hang Seng Healthcare Index rose by 1.34%. JingTai Technology (02228) rose by 21.84%.
Golden Guard Financial News | Pharmaceutical stocks show strong performance, with the Hang Seng Healthcare Index rising by 1.34%. Among them, Crystal Tai Technology quantumph-p (02228) rose by 21.84%, Yimingang Science (01541) rose by 9.94%, Zai Lab (09688) rose by 9.64%, Lifetech Sci (01302) rose by 5.22%, Lai Kai Medical (02105) rose by 5.52%, Tigermed (03347) rose by 5.36%. China Thai International stated that since October, there has been differentiation in the performance of pharmaceutical industry stocks. Among the components of the Hang Seng Healthcare Index, the stock prices have risen due to the previous stimulus from interest rate cuts.
LifeTech Scientific's (HKG:1302) Returns On Capital Not Reflecting Well On The Business
LifeTech Scientific Corporation (HKG:1302) May Have Run Too Fast Too Soon With Recent 27% Price PlummetNo Data
No Data
